If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Alessia Tieghi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles
Primary Myelofibrosis Medicine & Life Sciences
Essential Thrombocythemia Medicine & Life Sciences
Thrombosis Medicine & Life Sciences
Polycythemia Vera Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Multicenter Studies Medicine & Life Sciences
Thrombocytosis Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2020

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study

De Stefano, V., Ghirardi, A., Masciulli, A., Carobbio, A., Palandri, F., Vianelli, N., Rossi, E., Betti, S., Di Veroli, A., Iurlo, A., Cattaneo, D., Finazzi, G., Bonifacio, M., Scaffidi, L., Patriarca, A., Rumi, E., Casetti, I. C., Stephenson, C., Guglielmelli, P., Elli, E. M. & 23 others, Palova, M., Rapezzi, D., Erez, D., Gomez, M., Wille, K., Perez-Encinas, M., Lunghi, F., Angona, A., Fox, M. L., Beggiato, E., Benevolo, G., Carli, G., Cacciola, R., McMullin, M. F., Tieghi, A., Recasens, V., Isfort, S., Marchetti, M., Griesshammer, M., Alvarez-Larran, A., Vannucchi, A. M., Rambaldi, A. & Barbui, T., Jan 30 2020, In : Blood. 135, 5, p. 381-386 6 p.

Research output: Contribution to journalArticle

Second Primary Neoplasms
Case-Control Studies
Thrombosis
Neoplasms
Carcinoma

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study

De Stefano, V., Ghirardi, A., Masciulli, A., Carobbio, A., Palandri, F., Vianelli, N., Rossi, E., Betti, S., Di Veroli, A., Iurlo, A., Cattaneo, D., Finazzi, G., Bonifacio, M., Scaffidi, L., Patriarca, A., Rumi, E., Casetti, I. C., Stephenson, C., Guglielmelli, P., Elli, E. M. & 23 others, Palova, M., Rapezzi, D., Erez, D., Gomez, M., Wille, K., Perez-Encinas, M., Lunghi, F., Angona, A., Fox, M. L., Beggiato, E., Benevolo, G., Carli, G., Cacciola, R., McMullin, M. F., Tieghi, A., Recasens, V., Isfort, S., Marchetti, M., Griesshammer, M., Alvarez-Larran, A., Vannucchi, A. M., Rambaldi, A. & Barbui, T., 2020, In : Blood. 135, 5, p. 381-386 6 p.

Research output: Contribution to journalArticle

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

Venditti, A., Piciocchi, A., Candoni, A., Melillo, L., Calafiore, V., Cairoli, R., De Fabritiis, P., Storti, G., Salutari, P., Lanza, F., Martinelli, G., Luppi, M., Mazza, P., Martelli, M. P., Cuneo, A., Albano, F., Fabbiano, F., Tafuri, A., Chierichini, A., Tieghi, A. & 17 others, Fracchiolla, N. S., Capelli, D., Foà, R., Alati, C., Sala, E. L., Fazi, P., Vignetti, M., Maurillo, L., Buccisano, F., Del Principe, M. I., Irno-Consalvo, M., Ottone, T., Lavorgna, S., Voso, M. T., Lo-Coco, F., Arcese, W. & Amadori, S., Sep 19 2019, In : Blood. 134, 12, p. 935-945 11 p.

Research output: Contribution to journalArticle

Residual Neoplasm
Acute Myeloid Leukemia
Young Adult
Transplants
Stem cells

Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib

Palandri, F., Palumbo, G. A., Abruzzese, E., Iurlo, A., Polverelli, N., Elli, E., Bonifacio, M., Bergamaschi, M., Martino, B., Tiribelli, M., Benevolo, G., Tieghi, A., Sgherza, N., Isidori, A., Binotto, G., Crugnola, M., Heidel, F., Cavazzini, F., Bosi, C., Auteri, G. & 10 others, Cattaneo, D., Foà, R., Lemoli, R. M., Cuneo, A., Krampera, M., Bartoletti, D., Cavo, M., Vianelli, N., Breccia, M. & Latagliata, R., Oct 1 2019, In : Hematological Oncology. 37, 4, p. 418-423 6 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Leukemia
Spleen
INCB018424
Survival

Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib

Palandri, F., Palumbo, G. A., Abruzzese, E., Iurlo, A., Polverelli, N., Elli, E., Bonifacio, M., Bergamaschi, M., Martino, B., Tiribelli, M., Benevolo, G., Tieghi, A., Sgherza, N., Isidori, A., Binotto, G., Crugnola, M., Heidel, F., Cavazzini, F., Bosi, C., Auteri, G. & 10 others, Cattaneo, D., Foà, R., Lemoli, R. M., Cuneo, A., Krampera, M., Bartoletti, D., Cavo, M., Vianelli, N., Breccia, M. & Latagliata, R., 2019, In : Hematological Oncology. 37, 4, p. 418-423

Research output: Contribution to journalArticle